Sule Çataltepe

Sule Çataltepe

Auto-generated profile, based on publicly available information

Sule Çataltepe

Department of Pediatrics, Brigham and Women’s Hospital and Harvard Medical School , Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
XLXiaoliang Liang
Xiaoliang Liang
KGKushagra Gupta
Kushagra Gupta
JQJoselyn Rojas Quintero
Joselyn Rojas Quintero
MCManuela Cernadas
Manuela Cernadas
LKLester Kobzik
Lester Kobzik
SÇSule Çataltepe
Sule Çataltepe
Fatty acid binding protein 4 (FABP4), an intracellular lipid chaperone and adipokine, is expressed by lung macrophages, but the function of macrophage–FABP4 remains elusive. We investigated the role of FABP4 in host defense in a murine model of Pseudomonas aeruginosa pneumonia. Compared with wild‐type (WT) mice, FABP4‐deficient (FABP4 −/− ) mice exhibited decreased bacterial clearance and increased mortality when challenged in‐tranasally with P. aeruginosa . These findings in FABP4 −/− mice were associated with a delayed neutrophil recruitment into the lungs and were followed by greater acute lung injury and inflammation. Among leukocytes, only macrophages expressed FABP4 in WT mice with P. aeruginosa pneumonia. Chimeric FABP4 −/− mice with WT bone marrow were protected from increased mortality seen in chimeric WT mice with FABP4 −/− bone marrow during P. aeruginosa pneumonia, thus confirming the role of macrophages as the main source of protective FABP4 against that infection. There was less production of C‐X‐C motif chemokine ligand 1 (CXCL1) in FABP4 −/− alveolar macrophages and lower airway CXCL1 levels in FABP4 −/− mice. Delivering recombinant CXCL1 to the airways protected FABP4 −/− mice from increased susceptibility to P. aeruginosa pneumonia. Thus, macrophage‐FABP4 has a novel role in pulmonary host defense against P. aeruginosa infection by facilitating crosstalk between macrophages and neutrophils via regulation of macrophage CXCL1 production.—Liang, X., Gupta, K., Rojas Quintero, J., Cernadas, M., Kobzik, L., Christou, H., Pier, G. B., Owen, C. A., çataltepe, S. Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia. FASEB J. 33,3562–3574 (2019). www.fasebj.org

24 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSSourabh Soni
Sourabh Soni
YJYujie Jiang
Yujie Jiang
YTYohannes Tesfaigzi
Yohannes Tesfaigzi
JHJason L. Hornick
Jason L. Hornick
SÇSule Çataltepe
Sule Çataltepe
Angiotensin converting enzyme 2 (ACE2) is the putative functional receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Current literature on the abundance and distribution of ACE2 protein in the human respiratory tract is controversial. We examined the effect of age and lung injury on ACE2 protein expression in rodent and non-human primate (NHP) models. We also examined ACE2 expression in human tissues with and without coronavirus disease 19 (COVID-19). ACE2 expression was detected at very low levels in preterm, but was absent in full-term and adult NHP lung homogenates. This pattern of ACE2 expression contrasted with that of transmembrane protease serine type 2 (TMPRSS2), which was significantly increased in full-term newborn and adult NHP lungs compared to preterm NHP lungs. ACE2 expression was not detected in NHP lungs with cigarette smoke-induced airway disease or bronchopulmonary dysplasia. Murine lungs lacked basal ACE2 immunoreactivity, but responded to hyperoxia, bacterial infection, and allergen exposure with new ACE2 expression in bronchial epithelial cells. In human specimens, robust ACE2 immunoreactivity was detected in ciliated epithelial cells in paranasal sinus specimens, while ACE2 expression was detected only in rare type 2 alveolar epithelial cells in control lungs. In autopsy specimens from patients with COVID-19 pneumonia, ACE2 was detected in rare ciliated epithelial and endothelial cells in the trachea, but not in the lung. There was robust expression of ACE2 expression in F344/N rat nasal mucosa and lung specimens, which authentically recapitulated the ACE2 expression pattern in human paranasal sinus specimens. Thus, ACE2 protein expression demonstrates a significant gradient between upper and lower respiratory tract in humans and is scarce in the lung. This pattern of ACE2 expression supports the notion of sinonasal epithelium being the main entry site for SARS-CoV-2 but raises further questions on the pathogenesis and cellular targets of SARS-CoV-2 in COVID-19 pneumonia.

31 January 2017 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
KJKyoung Joung
Kyoung Joung
SCSule Umit Cataltepe
Sule Umit Cataltepe
ZMZoe Michael
Zoe Michael
helen christouhelen christou
helen christou
CMChristos S. Mantzoros
Christos S. Mantzoros
Context: Infants born small for gestational age (SGA) have increased risk for obesity and metabolic syndrome, but the underlying mechanisms are not fully elucidated. Adipocyte fatty acid–binding protein (AFABP) is an adipokine that has been implicated in modulation of insulin sensitivity and lipid metabolism. Higher plasma AFABP levels are associated with increased risk of metabolic syndrome and cardiovascular morbidity in adults. Alterations in AFABP levels during fetal growth have not been characterized. Objective: To examine AFABP levels in neonatal cord blood in relation to gestational age and birth weight. Design: A cross-sectional study of 361 neonates born at a tertiary academic center. Outcome Measures: Plasma AFABP levels were measured by enzyme-linked immunosorbent assay. For comparison, venous samples from 26 adults were analyzed. Results: AFABP levels were higher in neonates compared with adults (P < 0.01). Preterm infants had higher AFABP levels [48.2 (31.2 to 73.3) ng/mL] compared with full-term infants [35.8 (25.1 to 51.5)] ng/mL, P < 0.01). There was a negative correlation between AFABP and gestational age (r = 0.28, P = 0.02). Among full-term infants, AFABP levels in SGA infants were lower [28.6 (24.2 to 37.3) ng/mL], compared with appropriate for gestational age [36.1 (25.5 to 50.4) ng/mL] and large for gestational age infants [45.0 (24.6 to 62.4) ng/mL, P < 0.05]. Conclusions: These associations may reflect the higher metabolic activity during fetal development. AFABP may also be involved in fetal growth and the association between SGA status and obesity and metabolic syndrome in later life.

1 March 2023 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
SSSourabh Soni
Sourabh Soni
YJYujie Jiang
Yujie Jiang
LZLiang Zhang
Liang Zhang
ATAbhijeet Thakur
Abhijeet Thakur
SCSule Cataltepe
Sule Cataltepe
The pathogenesis of bronchopulmonary dysplasia (BPD) remains incompletely understood. Recent studies suggest insufficient AMP-activated protein kinase (AMPK) activation as a potential cause of impaired autophagy in rodent and nonhuman primate models of BPD. Impaired autophagy is associated with enhanced inflammatory signaling in alveolar macrophages (AMs) and increased severity of murine BPD induced by neonatal hyperoxia exposure. The goal of this study was to determine the role of autophagy and AMPK activation in macrophage responses in murine BPD. C57BL/6J mice were exposed to neonatal hyperoxia starting on postnatal day (P)1 and treated with the AMPK activator 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) between P3 and P6. Mice were euthanized on P7, and markers of AMPK activation and autophagy were assessed by immunoblotting. Alveolarization was assessed using radial alveolar counts, mean linear intercept measurements, and quantification of alveolar septal myofibroblasts. Relative mRNA expression of M1-like and M2-like genes was assessed in AMs isolated from BAL fluid from wild-type, LysMCre−-Becn1fl/fl, and LysMCre+-Becn1fl/fl mice after neonatal hyperoxia exposure. AICAR treatment resulted in AMPK activation and induction of autophagic activity in whole-lung and BAL cell lysates and attenuated hyperoxia-induced alveolar simplification in neonatal lungs. AICAR-treated control but not Beclin1-deficient AMs demonstrated significantly decreased expression of M1-like markers and significantly increased expression of M2-like markers. In conclusion, pharmacologic activation of AMPK by AICAR resulted in induction of autophagy and played a protective role, at least in part, through attenuation of proinflammatory signaling in AMs via autophagy-dependent mechanisms in a murine model of BPD.

11 November 2019 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
EEEbru Ergenekon
Ebru Ergenekon
SÇSule Çataltepe
Sule Çataltepe

18 August 2025 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
ATAbhijeet Thakur
Abhijeet Thakur
GCGeremy C. Clair
Geremy C. Clair
LZLiang Zhang
Liang Zhang
SSSourabh Soni
Sourabh Soni
TMThomas J Mariani
Thomas J Mariani
SÇSule Çataltepe
Sule Çataltepe
Bronchopulmonary dysplasia (BPD) is a chronic lung disease that affects preterm infants. Disrupted microvascular growth is a well-recognized pathologic feature of BPD, which plays a critical role in arrested alveologenesis. Recent studies have identified two subpopulations of pulmonary microvascular endothelial cells (ECs): general capillary (gCap) and aerocyte (aCap) cells. In this study, we validated proposed markers for gCap (GPIHBP1, PLVAP, CD93) and aCap (CA4, HPGD) at the protein level and investigated their abundance during late-stage lung development in murine and nonhuman primate (NHP) lungs. We also examined alterations in the abundance and proliferation of gCap and aCap cells in NHP and murine models of BPD. Our studies confirmed CA4 and HPGD as specific markers for aCap, and all three putative gCap markers were also detected in nonmicrovascular ECs. All markers except for HPGD showed a gradual increase in abundance during the saccular and alveolar stages of development in NHP lungs. In the NHP model of BPD, the abundance of both aCap markers and GPIHBP1 were decreased, whereas those of PLVAP and CD93 were increased. Additionally, there was an emergence of CA4+HPGD− aCap cells in BPD lungs. In late-stage control lungs, aCap proliferation was more robust than gCap proliferation, whereas no significant differences were observed between aCap and gCap proliferation rates in NHP BPD. Notably, in BPD lungs, gCap proliferation was more robust compared with control lungs. This study provides new insights into the distinct regulation patterns of microvascular ECs during lung development and neonatal lung injury in a translationally relevant NHP model.